DMSO: A Lung Disease Breakthrough? - AI Podcast
Dr. Joseph Mercola - Take Control of Your Health
Briana Mercola
4.6 • 1.5K Ratings
🗓️ 25 July 2025
⏱️ 8 minutes
🧾️ Download transcript
Summary
Story at-a-glance
- Chronic respiratory diseases remain profitable but poorly treated, subjecting patients to expensive healthcare, impaired stamina, and painful decline
- DMSO is an "umbrella remedy" treating diverse ailments through therapeutic properties including reducing inflammation, improving circulation, and reviving dying cells
- These properties uniquely address underlying causes of chronic respiratory diseases by reducing fibrosis and inflammation, restoring damaged organs, and improving circulation
- DMSO addresses respiratory infections through antimicrobial activity, reduced lung inflammation, and potentiation of antimicrobial therapies
- Extensive published data and user reports demonstrate DMSO's remarkable results for asthma, COPD, cystic fibrosis, interstitial lung disease, pulmonary fibrosis, and pneumonia, including cases in which transplant was no longer necessary due to significant organ recovery
Transcript
Click on a timestamp to play from that location
| 0:00.0 | What if a widely available compound could reduce your inflammation, improve your breathing, |
| 0:04.8 | and even help reverse some of the most feared chronic lung diseases without suppressing your immune system? |
| 0:11.0 | Welcome to Dr. Mercola's cellular wisdom. Stay informed with quick, easy-to-listen |
| 0:15.6 | summaries of our latest articles, perfect for when you're on the go. No reading required. |
| 0:20.2 | Subscribe for free at |
| 0:21.2 | Mercola.com for the latest health insights. |
| 0:24.7 | Hello and welcome to Dr. Mercola's cellular wisdom. I'm Ethan Foster and joining me is |
| 0:31.0 | Alara Sky. Today we're examining DMSO dimethyl sulfoxide and its surprising role in helping patients with chronic respiratory conditions |
| 0:40.5 | like COPD, asthma, and pulmonary fibrosis. Thanks, Ethan. Chronic respiratory diseases have become a |
| 0:48.4 | highly profitable, yet poorly managed sector in medicine. Patients face costly treatments, |
| 0:54.0 | frequent hospitalizations, and long-term |
| 0:55.8 | disability. What stands out about DMSO is how it addresses some of the underlying causes, |
| 1:01.2 | fibrosis, inflammation, and poor circulation, rather than just managing symptoms. |
| 1:06.3 | Let's begin with C-O-P-D. For many patients, C-O-P-D means a cycle of hospitalizations, steroid use, and |
| 1:14.3 | increasing respiratory failure. But DMSO offers a different approach. It reduces inflammation, |
| 1:21.2 | restores damaged tissue, and enhances circulation, targeting the actual mechanisms behind the disease. |
| 1:27.1 | And there's another piece to that puzzle. |
| 1:29.3 | The lungs naturally concentrate glutathione, a powerful antioxidant, to protect against damage. |
| 1:35.3 | In chronic lung disease, this protective layer is depleted. |
| 1:39.3 | Nebulized glutathione has shown promise in restoring that coating, |
| 1:43.3 | especially in COPD exacerbations. |
| 1:46.6 | It's been helpful for patients, including those with wildfire damage, though it's not commonly |
... |
Transcript will be available on the free plan in 7 days. Upgrade to see the full transcript now.
Disclaimer: The podcast and artwork embedded on this page are from Briana Mercola, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Briana Mercola and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.